Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...

Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.

Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...

It’s a grand slam partnership for telehealth provider Ro. World renowned tennis star Serena Willams is partnering with the ...

Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...

Large U.S. companies expect their health care costs to rise a median of 9% in 2026, according to a survey by the Business Group on Health. That is up from an expected 8% jump in 2025 and the steepest ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.